References
- Garr M. D., Paller M. S. Cyclosporine augments renal but not systemic vascular reactivity. Am. J. Physiol. 1990; 258: F211–F217
- Scherrer U., Vissing S. F., Morgan B. J., Rollins J. A., Tindall R. S., Ring S., Hanson P., Mohanty P. K., Victor R. G. Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N. Engl. J. Med. 1990; 693–699
- Textor S. C., Canzanello V. J., Taler S. J., Wilson D. J., Schwartz L. L., Augustine J. E., Raymer J. M., Romero J. C., Wiesner R. H., Krom R. A., et al. Cyclosporine-induced hypertension after transplantation. Mayo Clinic. Proceedings 1994; 69: 1182–1193
- Lyson T., McMullan D. M., Ermel L. D., Morgan B. J., Victor R. G. Mechanism of cyclosporine-induced sympathetic activation and acute hypertension in rats. Hypertension 1994; 23: 667–675
- Julien J., Farge D., Kreft-Jais C., Guyene T. T., Plouin P. F., Houssin D., Carpentier A., Corvol P. Cyclosporine-induced stimulation of the renin-angiotensin system after liver and heart transplantation. Transplantation 1993; 56: 885–891
- Diederich D., Skopec J., Diederich A., Dai F. X. Cyclosporine produces endothelial dysfunction by increased production of superoxide. Hypertension 1994; 23: 957–961
- Roullet J. B., Xue H., McCarron D. A., Holcomb S., Bennett W. M. Vascular mechanisms of cyclosporin-induced hypertension in the rat. J. Clin. Invest 1994; 93: 2244–2250
- Grieff M., Loertscher R., Shohaib S. A., Stewart D. J. Cyclosporine-induced elevation in circulating endothelin-1 in patients with solid-organ transplants. Transplantation 1993; 56: 880–884
- Conger J. D., Kim G. E., Robinette J. B. Effects of ANG II, ETA, and TXA2 receptor antagonists on cyclosporin A renal vasoconstriction. Am. J. Physiol. 1994; 267: F443–F449
- Iwai J., Kanayama Y., Inoue N. N., Okamura M., Takeda T. Increased endothelial gene expression of angiotensin AT1A receptor in cyclosporine induced hypertensive rats. Eur. J. of Pharmacol. 1993; 248: 341–344
- Iwai J., Kanayama Y., Negoro N., Inoue T., Okamura M., Takeda T. Increased gene expression of angiotensin II type 1A receptor in aortic smooth muscle cells of cyclosporin A-induced hypertensive rats. J. Hypertens. 1993; 11: S122–S123
- Mason J. Pharmacology of cyclosporine (sandimmune). VII. Pathophysiology and toxicology of cyclosporine in humans and animals. Pharmacol. Rev. 1990; 41: 423–434
- Feutren G., Mihatsch M. J. Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. International Kidney Biopsy Registry of Cyclosporine in Autoimmune Diseases. N Engl. J. Med. 1992; 326: 1654–1660
- Pfeilschifter J., Rüegg U. T. Cyclosporin A augments angiotensin II-stimulated rise in intracellular free calcium in vascular smooth muscle cells. Biochem J. 1987; 248: 883–887
- Lo Russo A., Passaquin A. C., André P., Skutella M., Rüegg U. T. Effect of cyclosporin A and analogues on cytosolic calcium and vasoconstriction: lack of relationships to immunosuppression. Br. J. Pharmacol. 1996, In Press
- Berridge M. J. Inositol trisphosphate and calcium signalling. Nature 1993; 361: 315–325
- Knot H. J., de Ree M. M., Gähwiler B. H., Rüegg U. T. Modulation of electrical activity and of intracellular calcium oscillations of smooth muscle cells by calcium antagonists, agonists, and vasopressin. J. Cardiovasc. Pharmacol. 1991; 18: S7–14
- Grynkiewicz G., Poenie M., Tsien R. Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 1985; 260: 3440–3450
- Antonny B., Sukumar M., Bigay J., Chabre M., Higashijima T. The mechanism of aluminum-independent G-protein activation by fluoride and magnesium. 31P NMR spectroscopy and fluorescence kinetic studies. J. Biol. Chem. 1993; 268: 2393–2402
- Schreiber S. L., Crabtree G. R. The mechanism of action of cyclosporin A and FK506. Immunol. Today 1992; 13: 136–142
- Himpens B., Missiaen L., Casteels R. Ca2+ homeostasis in vascular smooth muscle. Journal of Vascular Research 1995; 32: 207–219
- Wenger R. M., Payne T. G., Schreier M. H. Cyclosporine: chemistry, structure-activity relationships and mode of action, Prog. Clin. Biochem. and Med. 1986; 3: 157–191
- McNally P. G., Heagerty A. M., Walls J., Feehally J. Phosphoinositide hydrolysis is not enhanced by ciclosporin. Nephron 1991; 59: 512–514
- Nambi P., Pullen M., Contino L. C., Brooks D. P. Upregulation of renal endothelin receptors in rats with cyclosporine A-induced nephrotoxicity. Eur. J. Pharmacol. 1990; 187: 113–116
- Tufro-McReddie A., Gomez R. A., Norling L. L., Omar A. A., Moore L. C., Kaskel F. J. Effect of CsA on the expression of renin and angiotensin type 1 receptor genes in the rat kidney. Kidney Int. 1993; 43: 615–622